. Before the analysis each frame was superposed with the backbone atoms of TM 17 of the MD starting structure.
ICL3 GsαCT β 2 AR*
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Figure S4
Cationπ interactions between β 2 AR* and (A) Gsαβγ, (B) GsαCT 19 , (C) GsαCT 11 and between (D) RhR* and GsαCT 19 . Each plot shows the data of multiple MD simulations, each between 200 and 500 ns long. See Table 1 Polar interactions between R* and GαCT. Each plot shows the data of multiple MD simulation, each between 100 and 600 ns long. The lengths of the individual simulations are given in Table S1 . The timeseries denote one (black), two (blue) or three (green) polar interactions between two residues as observed in the MD simulations of (A) β 2 
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Figure S9
Alignment of GαCT 19 sequences colored by similarity.
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Supplemental Information Methods
Preparations of active receptor (R*) and GαCT structures and complexes
The starting conformations used for MD simulations were prepared based on X-ray structures from co-crystals of β 2 AR*•Gsαβγ (PDB entry 3SN6) [1] and of RhR*•GtαCT (PDB entry 3PQR) [2] . The far C-termini of both R* structures (RhR*: residues 327 to 348, UniProt entry P02699; β 2 AR*: 342-413, UniProt entry P07550), not resolved in these complexes, were not modeled because they seem not to affect Gt activation [3] . [4] . Three stabilizing mutants (M96T, M98T and N187E) in β 2 AR* were changed back to the wild-type form. The coordinates for the missing residues of the extracellular loop (ECL) 2 (176-178) were taken from the β 2 AR* structure (PDB entry 3P0G) where ECL 2 is resolved [5] . The conformation of residues 240 to 264 from the intracellular loop (ICL) 3, which are not critical to receptor function [6] , were modeled with help of the fragment based loop modeling program SuperLooper [7] .
Gsαβγ was prepared as follows. The missing Gsα N-terminal residues 1-8 were modeled using standard geometries before a palmitoyl chain was ligated to C3 and G2 [8] . A geranylgeranyl chain was ligated to residue 68 of the Gsγ-subunit [9] , after the missing residues 1-4 of the N-terminus and 63-68 of the C-terminus were added. The mutated residues G72S in Gsα and M1Q in the Gsβ were changed back to the wild- [4] . The conformation of the missing residues 60-70, 85-87, 203-204 and 256-262 in Gsα, were again modeled with SuperLooper [7] .
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For all MD simulations of RhR* two palmitoyl chains were attached to the residues C322 and C323. The coordinates from the double high-affinity K341L, C347V peptide variant in complex with RhR* (PDB entry 3PQR) were used. After back mutation of these two residues, RhR* in complex with native 11-mer GtαCT was obtained (340-350). For simulations of 19-mer GtαCT (332-350) the 11-mer GtαCT was extended Nterminally by 8 amino acids using the geometries of an ideal α-helix. For simulations of 11-mer GsαCT (residues 384-394) and 19-mer GsαCT (residues 376-394) the coordinates from the β 2 AR*•Gsαβγ complex were used.
Protonation states and internal water
The C-termini of GsαCT, GtαCT, GiαCT, RhR* and β 2 AR* were deprotonated (COO − ), whereas the N-termini were fully protonated (NH3 + ). In RhR*, D83 [10, 11] , E113 [12] , E122 [11] and E134 [13] were protonated. In β 2 AR*, E122 was protonated, because it is in close contact with the hydrophobic lipid tails in the middle of the lipid bilayer (as suggested by Dror et al. [14] ). All other protonation states were defined according to their respective pKa values (provided by GROMACS).
Empty polar water sized internal cavities were filled with water molecules by means of the program DOWSER [15] .
Preparation of the β 2 AR*•GiαCT complex
The β 2 AR*•GiαCT 19 and TM5, but allowed to move freely within the R* binding crevice. In the simulations where TM6 tilts inwards (Fig. 2C, S2E ) the cytoplasmic crevice closes and a tight interaction is formed with TM6 (Fig. 3B, S5D ).
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Preparation of the RhR*•GsαCT complex
The GsαCT starting position for the RhR*•GsαCT complex was obtained following the same sequence alignment and superposition protocol as for β 2 AR*•GiαCT but with RhR* as the receptor and GsαCT as the peptide target.
Molecular dynamics protocol
System preparation and subsequent minimization and equilibration were performed with the GROMACS suite (version 4.5) [16] . The proteins were inserted into the equilibrated bilayer of dimyristoylphosphatidylcholine (DMPC) using the GROMACS g_membed tool [17] . Parameters for the DMPC lipids were derived from Berger et al. [18] and for water from the SPC/E model [19] . A salt concentration of 0.15 mol/L was obtained by adding Na + and Cl − ions to the system with the GROMACS tool genion.
The AMBER99SB-ILDN force field [20] was used for proteins and ions. Ligand parameters for the agonist 5-hydroxy-4H-benzo [1, 4] oxazin-3-one (a.k.a. BI-167107)
of β 2 AR* were created with the PRODRG2 webserver [21] . Parameters for the deprotonated all-trans retinal in RhR* were adapted from Mertz et al. [22] To obtain clash-free structures suitable for MD simulations, an energy minimization was performed in GROMACS using the steepest descent algorithm until the maximum force went below 1000.0 kJ/mol/nm. In the following equilibration step the energy minimized structure was simulated for 20 ns with all protein backbone atoms restrained to their initial positions. This allows for relaxation at the protein-membrane, protein-water and the membrane-water interfaces so that voids are filled and side chain packing is optimized. For the production MD simulations the position restraints were lifted.
Based on the equilibrated systems, the production runs were started with different initial velocities obtained from Boltzmann distributions at 320 K. For equilibration and the production runs all bonds were constrained using the LINCS algorithm [23] , with the exception of water bonds, which were constrained by the SETTLE algorithm [24] .
The temperature was kept constant by coupling the system to a temperature bath of 320 K, which is high enough to keep the DMPC membrane from entering the gel phase. The temperature coupling was performed using the velocity-rescaling thermostat of Bussi et al. [25] with a time constant of 0.2 ps. Long range electrostatics
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were calculated with the PME method [26] . Berendsen pressure coupling was performed with a time constant of 2.0 ps and semi-isotropic scaling separating scaling in the membrane plane directions from the z-direction (i.e the membrane plane normal). The integration time step used for all simulations was 0.002 ps.
Umbrella sampling
Umbrella sampling (US) facilitates sampling of the conformational space by applying a restraining potential along a transition coordinate. By employing umbrella sampling over a series of windows a range of the transition coordinates can be sampled which would be inaccessible to direct sampling due to energy barriers of the transition coordinate. The resulting series of histograms contains the biased distribution along the transition coordinate. The weighted histogram analysis method is employed to unbias and combine the histograms [27] . From the resulting distribution the potential of mean force can be calculated as PMF(c) = −k B T ln〈p(c) 〉 for the probability p of the transition coordinate c.
Here, the transition coordinate for the free energy calculations of TM6 inward movement and β 2 AR* GiαCT interaction was selected from the trajectories of a series of β 2 AR*•GiαCT 19-mer MD simulations (Fig. S2E, simulation 8 ). Along the selected trajectory, umbrella sampling MD simulations were performed with respect to the TM6 inward transition, by applying the umbrella potential to the upper part of TM6, namely to the backbone atoms of residues 265 to 277. We simulated 36 US windows for 200 ns, each. WHAM was then employed to obtain the PMFs from the last 100 ns from each US window and the error was estimated by the standard deviation of a blockwise (three equally sized blocks) analysis.
TM6 tilt
The distance between TM2 and 6 (dTM2-6) was used as an indicator of the TM6 tilt. It is measured as the distance between the geometric centers for intracellular sections of TM2 and TM6. For TM2 we used the backbone atom positions of the residues 71-75 (RhR*) and 67-71 (β 2 AR*); for TM6 244-248 and 265-269, respectively.
